Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
Clinical trial NCT04445272 · COMPLETED
Trial details
- NCT number
- NCT04445272
- Sponsor
- Fundacion SEIMC-GESIDA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-22
- Primary completion
- 2020-12-23
- Enrollment
- 495
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.